Literature DB >> 11073537

Characterisation and genetic mapping of a new X linked deafness syndrome.

D M Martin1, F J Probst, S A Camper, E M Petty.   

Abstract

BACKGROUND: Hereditary forms of hearing loss are classified as syndromic, when deafness is associated with other clinical features, or non-syndromic, when deafness occurs without other clinical features. Many types of syndromic deafness have been described, some of which have been mapped to specific chromosomal regions.
METHODS: Here we describe a family with progressive sensorineural hearing loss, cognitive impairment, facial dysmorphism, and variable other features, transmitted by apparent X linked recessive inheritance. Haplotype analysis of PCR products spanning the X chromosome and direct sequencing of candidate genes were used to begin characterising the molecular basis of features transmitted in this family. Comparison to known syndromes involving deafness, mental retardation, facial dysmorphism, and other clinical features was performed by review of published reports and personal discussions.
RESULTS: Genetic mapping places the candidate locus for this syndrome within a 48 cM region on Xq1-21. Candidate genes including COL4A5, DIAPH, and POU3F4 were excluded by clinical and molecular analyses.
CONCLUSIONS: The constellation of clinical findings in this family (deafness, cognitive impairment, facial dysmorphism, variable renal and genitourinary abnormalities, and late onset pancytopenia), along with a shared haplotype on Xq1-21, suggests that this represents a new form of syndromic deafness. We discuss our findings in comparison to several other syndromic and non-syndromic deafness loci that have been mapped to the X chromosome.

Entities:  

Mesh:

Year:  2000        PMID: 11073537      PMCID: PMC1734461          DOI: 10.1136/jmg.37.11.836

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  X-linked deafness, stapes gushers and a distinctive defect of the inner ear.

Authors:  P D Phelps; W Reardon; M Pembrey; S Bellman; L Luxom
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

3.  XNP mutation in a large family with Juberg-Marsidi syndrome.

Authors:  L Villard; J Gecz; J F Mattéi; M Fontés; P Saugier-Veber; A Munnich; S Lyonnet
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

4.  Hereditary postlingual sensorineural hearing loss mapping to chromosome Xq21.

Authors:  E N Manolis; R D Eavey; S Sangwatanaroj; C Halpin; S Rosenbaum; H Watkins; J Jarcho; C E Seidman; J G Seidman
Journal:  Am J Otol       Date:  1999-09

5.  Deletion mapping of X-linked mixed deafness (DFN3) identifies a 265-525-kb region centromeric of DXS26.

Authors:  N Dahl; J Laporte; L Hu; V Biancalana; D Le Palier; D Cohen; C Piussan; J L Mandel
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

6.  A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness.

Authors:  H Jin; M May; L Tranebjaerg; E Kendall; G Fontán; J Jackson; S H Subramony; F Arena; H Lubs; S Smith; R Stevenson; C Schwartz; D Vetrie
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

7.  Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21.

Authors:  D E Merry; J G Lesko; D M Sosnoski; R A Lewis; M Lubinsky; B Trask; G van den Engh; F S Collins; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

8.  Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4.

Authors:  Y J de Kok; S M van der Maarel; M Bitner-Glindzicz; I Huber; A P Monaco; S Malcolm; M E Pembrey; H H Ropers; F P Cremers
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

9.  Choroideremia, congenital deafness and mental retardation in a family with an X chromosomal deletion.

Authors:  T Rosenberg; E Niebuhr; H M Yang; A Parving; M Schwartz
Journal:  Ophthalmic Paediatr Genet       Date:  1987-11

10.  X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.

Authors:  A Renieri; M Bruttini; L Galli; P Zanelli; T Neri; S Rossetti; A Turco; N Heiskari; J Zhou; R Gusmano; L Massella; G Banfi; F Scolari; A Sessa; G Rizzoni; K Tryggvason; P F Pignatti; M Savi; A Ballabio; M De Marchi
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

View more
  4 in total

1.  Mutation in the X-linked RAB40AL gene (Martin-Probst syndrome) with mental retardation, sensorineural hearing loss, and anomalies of the craniofacies and genitourinary tract: a second case report.

Authors:  James Lee; Stacey Wong; Richard G Boles
Journal:  Eur J Pediatr       Date:  2014-05-27       Impact factor: 3.183

Review 2.  Ethical issues in neonatal and pediatric clinical trials.

Authors:  Naomi Laventhal; Beth A Tarini; John Lantos
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

3.  A note of caution on the diagnosis of Martin-Probst syndrome by the detection of the p.D59G mutation in the RAB40AL gene.

Authors:  Monika Ołdak; Ewelina Ruszkowska; Agnieszka Pollak; Agnieszka Sobczyk-Kopcioł; Cezary Kowalewski; Aleksandra Piwońska; Wojciech Drygas; Rafał Płoski
Journal:  Eur J Pediatr       Date:  2014-11-05       Impact factor: 3.183

4.  Disruption of RAB40AL function leads to Martin--Probst syndrome, a rare X-linked multisystem neurodevelopmental human disorder.

Authors:  Jirair Krikor Bedoyan; Valerie M Schaibley; Weiping Peng; Yongsheng Bai; Kajari Mondal; Amol C Shetty; Mark Durham; Joseph A Micucci; Arti Dhiraaj; Jennifer M Skidmore; Julie B Kaplan; Cindy Skinner; Charles E Schwartz; Anthony Antonellis; Michael E Zwick; James D Cavalcoli; Jun Z Li; Donna M Martin
Journal:  J Med Genet       Date:  2012-05       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.